🧵 4. Gene therapies costing over $1 million pose a significant financial risk for employers, with half a dozen approved in the US last year.
You are viewing a single comment's thread from:
🧵 4. Gene therapies costing over $1 million pose a significant financial risk for employers, with half a dozen approved in the US last year.